Class I medical rehabilitation aids (manual wheelchairs, orthopedic supports, crutches, basic training equipment, etc.) are experiencing concentrated import policy benefits globally as the world's population ages and the demand for rehabilitation rises. This condensed guide helps importers reduce costs and increase competitiveness by outlining key preferential policies across important markets with official sources.
I. Europe & US: Tariff Cuts + VAT Exemptions
Mature markets with robust policies focusing on cost reduction and vulnerable group protection.
1. EU
Per Council Regulation (EEC) No 2913/92, Class I aids circulate tariff-free within the EU (28 member states + EEA). For non-EU imports (e.g., China), most face 0-3% tariffs per EU TARIC (verify via http://madb.europa.eu/madb/euTariffs.htm). Germany, France, and the UK offer VAT perks: France applies 2.1% VAT (vs. 20% standard) for disability-specific aids; the UK grants 0% VAT via self-declaration (no medical certs). Class I products are exempt from Notified Body (NB) certification—only EC REP entrustment and EUDAMED registration (1-2 months) are needed. Note: EU Implementing Regulation 2025/1197 restricts Chinese firms in public procurement; check compliance first.
2. US
Under the Nairobi Protocol, disability-specific Class I aids (diabetic rehab gear, mobility crutches) enjoy duty-free import. Per CBP’s HTS, most others have ≤2% tariffs, with basics (grip strengtheners) at 0%. FDA exempts Class I from 510(k) pre-market notification—only FDA registration, product listing, and US Agent appointment are required. Annual renewal (＜$500) maintains validity.
II. Southeast Asia: FTA Dividends + Subsidies
Fast-growing markets are using policies to fill supply gaps.
1. Vietnam & Indonesia
Vietnam offers 0% tariffs and 8% VAT (vs 10% standard) for medical-use Class I aids; full exemption for public hospital/epidemic projects (per GACC Announcement 2023 No.20). Indonesia’s 2025新政 (effective Jan 1) exempts import tax/VAT for disability-specific Class I aids (crutches, basic gear). Cambodia adds lab rehab equipment to zero-tariff list from Jan 1, 2026.
2. Philippines & Malaysia
The Philippines cuts tariffs from 12% to 5% via "Tax Exemption Act for Disabled Persons’ Medical Devices" (8-12% retail cut). Govt procurement grows 12-15% annually (2025-2030). Malaysia offers 0% tariffs for ASEAN imports and 5-8% for non-ASEAN (verify via Malaysian Customs)；VAT exemption available with local agent cooperation.
III. Japan, Australia: Low Tariffs + Welfare Linkage
Stringent access but targeted policies tied to local welfare systems.
1. Japan
PMDA policies set 0-2% tariffs for Class I aids. Simplified registration (3-4 weeks) via local MAH/DMAH is required. Japan’s Long-Term Care Insurance covers 75-90% of costs for the disabled/elderly, boosting demand.
2. Australia
ChAFTA grants 0% tariffs for Chinese imports (crutches, pressure sore mattresses; verify via DFAT). 10% GST exemption applies to disability/rehab institution purchases. ARTG registration (per TGA rules) unlocks both benefits.
IV. Emerging Markets: Intensive Dividends
Russia’s updated "VAT-Exempt Medical Devices List" (official gazette) includes Class I aids with 0-5% tariffs. Uzbekistan offers 3-10 years of full tariff/income tax exemption for Class I production gear imports in free zones (70% import dependence, official data).
V. Global Essentials
1. Compliance first: Complete target market registration (EU: EC REP+EUDAMED; US: FDA; Japan: PMDA).
2. Secure Certificate of Origin (Form A/E for China-EU, Form E for ASEAN, ChAFTA COO).
3. Match eligibility via official channels (EU MDR, US FDA database, Japan PMDA guidelines).
Conclusion: These policies are a precise response to rehabilitation needs. Mastering official requirements and policy details helps importers reduce costs and expand markets. With global FTA expansion, preferences will strengthen—early compliance secures opportunities.